Results 11 to 20 of about 10,287 (203)

Studies on hypolipidemic agents. II Synthesis of 1-arenesulfonyloxy-2-alkanone derivatives as potent esterase inhibitors and hypolipidemic agents.

open access: bronzeChemical and Pharmaceutical Bulletin, 1986
Many 2-oxoalkyl arenesulfonate derivatives having straight or branched alkyl chains of different lengths, 2-oxoalkyl bis-arenesulfonate derivatives, and alkyl arenesulfonate derivatives having a ketal moiety at the 2-position on the alkyl chain were synthesized, and their esterase-inhibitory activities, as well as hypolipidemic activities, were ...
Kazuo Ogawa   +5 more
openalex   +5 more sources

Inhibition of Hepatic Acetyl Coenzyme A Carboxylase by Hypolipidemic Agents

open access: hybridJournal of Biological Chemistry, 1969
Abstract The effects of two hypolipidemic agents, 2-methyl-2-[p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy]propionate and ethyl 2-(p-chlorophenyl)-2-methylpropionate, on the activity of a highly purified preparation of acetyl coenzyme A carboxylase, obtained from chicken livers, were studied.
Michael E. Maragoudakis
openalex   +4 more sources

Persistence and Adherence to Cardiovascular Medicines in Australia

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa   +5 more
doaj   +1 more source

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundAtherosclerotic cardiovascular diseases (ASCVD) and dyslipidemia are associated to a higher risk of cardiovascular events, mortality, use of healthcare resources and costs.
Vivencio Barrios   +17 more
doaj   +1 more source

Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018

open access: yesScandinavian Journal of Primary Health Care, 2023
Objective To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia.Design Epidemiological cohort study.Setting Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre.Subjects ...
Marius Mølsted Flege   +6 more
doaj   +1 more source

Unlocking the Medicinal Mysteries: Preventing Lacunar Stroke with Drug Repurposing

open access: yesBiomedicines, 2023
Currently, only the general control of the risk factors is known to prevent lacunar cerebral infarction, but it is unknown which type of medication for controlling the risk factors has a causal relationship with reducing the risk of lacunar infarction ...
Linjing Zhang   +6 more
doaj   +1 more source

Hypolipidemic agents [PDF]

open access: bronzeAnnals of Internal Medicine, 1977
Helmut Sies
openalex   +2 more sources

Antioxidant and Hypolipidemic Activities of Cinnamic Acid Derivatives

open access: yesMolecules, 2023
Oxidative stress and hyperlipidemia are important factors for the initiation and progression of various cell degenerative pathological conditions, including cardiovascular and neurological diseases.
Christina Nouni   +2 more
doaj   +1 more source

Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled Trial

open access: yesJournal of Cardiovascular Development and Disease, 2022
Elevated circulating lipoprotein(a) levels are associated with an increased risk of cardiovascular events. We reported that early initiation of evolocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, in addition to a statin substantially ...
Tomoaki Okada   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy